Clinical Trial Update: Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/3 trial evaluating the Towne strain CMV vaccine in seronegative women was terminated, with safety and immune response results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Towne Strain CMV vaccine (cytomegalovirus vaccine (Towne strain))

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Cytomegalovirus Infections | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-05-30